tirzepatide hfpef ESC 2025: study supports use of semaglutide, in cardiometabolic patients 💊 New research in obesity

Graphic Abstract Similar content being viewed by others Digital Features This article is published with digital features, including a summary slide and graphical abstract, to facilitate understanding of the article

They can also help if youre not losing the expected amount of weight on Wegovy

Key Takeaway: Bupropion-naltrexone (Contrave) is FDA-approved for weight management, validating the bupropion role How Do Appetite Suppression Effects Stack

Makowicki hasnt yet spoken with her physician about a plan, but shes set to graduate from UConn in May and hopes to secure a job with insurance benefits that will cover GLP-1s

Not crash-diet fast, but sustainable

Compounded GLP-1 medications are prepared by a pharmacist for each individual patient, sometimes at different doses or with different active forms of the drug than the FDA approved, brand-name medications